These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38293170)

  • 1. An integrated technology for quantitative wide mutational scanning of human antibody Fab libraries.
    Petersen BM; Kirby MB; Chrispens KM; Irvin OM; Strawn IK; Haas CM; Walker AM; Baumer ZT; Ulmer SA; Ayala E; Rhodes ER; Guthmiller JJ; Steiner PJ; Whitehead TA
    bioRxiv; 2024 Jan; ():. PubMed ID: 38293170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An integrated technology for quantitative wide mutational scanning of human antibody Fab libraries.
    Petersen BM; Kirby MB; Chrispens KM; Irvin OM; Strawn IK; Haas CM; Walker AM; Baumer ZT; Ulmer SA; Ayala E; Rhodes ER; Guthmiller JJ; Steiner PJ; Whitehead TA
    Nat Commun; 2024 May; 15(1):3974. PubMed ID: 38730230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
    Wu H; Nie Y; Huse WD; Watkins JD
    J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SAMURAI (Solid-phase Assisted Mutagenesis by Uracil Restriction for Accurate Integration) for antibody affinity maturation and paratope mapping.
    Hu FJ; Lundqvist M; Uhlén M; Rockberg J
    Nucleic Acids Res; 2019 Apr; 47(6):e34. PubMed ID: 30715449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDR-H3 diversity is not required for antigen recognition by synthetic antibodies.
    Persson H; Ye W; Wernimont A; Adams JJ; Koide A; Koide S; Lam R; Sidhu SS
    J Mol Biol; 2013 Feb; 425(4):803-11. PubMed ID: 23219464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and Thermodynamic Basis of Epitope Binding by Neutralizing and Nonneutralizing Forms of the Anti-HIV-1 Antibody 4E10.
    Rujas E; Gulzar N; Morante K; Tsumoto K; Scott JK; Nieva JL; Caaveiro JM
    J Virol; 2015 Dec; 89(23):11975-89. PubMed ID: 26378169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput generation of synthetic antibodies from highly functional minimalist phage-displayed libraries.
    Fellouse FA; Esaki K; Birtalan S; Raptis D; Cancasci VJ; Koide A; Jhurani P; Vasser M; Wiesmann C; Kossiakoff AA; Koide S; Sidhu SS
    J Mol Biol; 2007 Nov; 373(4):924-40. PubMed ID: 17825836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hallucinating structure-conditioned antibody libraries for target-specific binders.
    Mahajan SP; Ruffolo JA; Frick R; Gray JJ
    Front Immunol; 2022; 13():999034. PubMed ID: 36341416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ablation of the complementarity-determining region H3 apex of the anti-HIV-1 broadly neutralizing antibody 2F5 abrogates neutralizing capacity without affecting core epitope binding.
    Julien JP; Huarte N; Maeso R; Taneva SG; Cunningham A; Nieva JL; Pai EF
    J Virol; 2010 May; 84(9):4136-47. PubMed ID: 20147404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold.
    Lee CV; Liang WC; Dennis MS; Eigenbrot C; Sidhu SS; Fuh G
    J Mol Biol; 2004 Jul; 340(5):1073-93. PubMed ID: 15236968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and analysis of the improved human HAL9/10 antibody phage display libraries.
    Kügler J; Wilke S; Meier D; Tomszak F; Frenzel A; Schirrmann T; Dübel S; Garritsen H; Hock B; Toleikis L; Schütte M; Hust M
    BMC Biotechnol; 2015 Feb; 15():10. PubMed ID: 25888378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grabbing the Bull by Both Horns: Bovine Ultralong CDR-H3 Paratopes Enable Engineering of 'Almost Natural' Common Light Chain Bispecific Antibodies Suitable For Effector Cell Redirection.
    Klewinghaus D; Pekar L; Arras P; Krah S; Valldorf B; Kolmar H; Zielonka S
    Front Immunol; 2021; 12():801368. PubMed ID: 35087526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep Sequencing-guided Design of a High Affinity Dual Specificity Antibody to Target Two Angiogenic Factors in Neovascular Age-related Macular Degeneration.
    Koenig P; Lee CV; Sanowar S; Wu P; Stinson J; Harris SF; Fuh G
    J Biol Chem; 2015 Sep; 290(36):21773-86. PubMed ID: 26088137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of two murine monoclonal antibodies humanized by CDR-grafting and variable domain resurfacing.
    Roguska MA; Pedersen JT; Henry AH; Searle SM; Roja CM; Avery B; Hoffee M; Cook S; Lambert JM; Blättler WA; Rees AR; Guild BC
    Protein Eng; 1996 Oct; 9(10):895-904. PubMed ID: 8931129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering and characterising a novel, highly potent bispecific antibody iMab-CAP256 that targets HIV-1.
    Moshoette T; Ali SA; Papathanasopoulos MA; Killick MA
    Retrovirology; 2019 Nov; 16(1):31. PubMed ID: 31703699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.
    Qiu Y; Stegalkina S; Zhang J; Boudanova E; Park A; Zhou Y; Prabakaran P; Pougatcheva S; Ustyugova IV; Vogel TU; Mundle ST; Oomen R; Delagrave S; Ross TM; Kleanthous H; Qiu H
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31826999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of rare mutational outcomes to broadly neutralizing antibodies.
    Feng A; Hao Q; Yeap LS
    Acta Biochim Biophys Sin (Shanghai); 2022 May; 54(6):820-827. PubMed ID: 35713319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.
    Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M
    J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a high-affinity human antibody with a disulfide bridge in the third complementarity-determining region of the heavy chain.
    Almagro JC; Raghunathan G; Beil E; Janecki DJ; Chen Q; Dinh T; LaCombe A; Connor J; Ware M; Kim PH; Swanson RV; Fransson J
    J Mol Recognit; 2012 Mar; 25(3):125-35. PubMed ID: 22407976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational fitness landscapes reveal genetic and structural improvement pathways for a vaccine-elicited HIV-1 broadly neutralizing antibody.
    Madan B; Zhang B; Xu K; Chao CW; O'Dell S; Wolfe JR; Chuang GY; Fahad AS; Geng H; Kong R; Louder MK; Nguyen TD; Rawi R; Schön A; Sheng Z; Nimrania R; Wang Y; Zhou T; Lin BC; Doria-Rose NA; Shapiro L; Kwong PD; DeKosky BJ
    Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33649208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.